Does TACROLIMUS Cause Bronchopulmonary aspergillosis? 968 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 968 reports of Bronchopulmonary aspergillosis have been filed in association with TACROLIMUS (Tacrolimus). This represents 1.1% of all adverse event reports for TACROLIMUS.
968
Reports of Bronchopulmonary aspergillosis with TACROLIMUS
1.1%
of all TACROLIMUS reports
362
Deaths
613
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From TACROLIMUS?
Of the 968 reports, 362 (37.4%) resulted in death, 613 (63.3%) required hospitalization, and 244 (25.2%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 968 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Bronchopulmonary aspergillosis?
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
CYTARABINE (550)
Which TACROLIMUS Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB